These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 26099011

  • 1. Heterogenous MSH6 loss is a result of microsatellite instability within MSH6 and occurs in sporadic and hereditary colorectal and endometrial carcinomas.
    Graham RP, Kerr SE, Butz ML, Thibodeau SN, Halling KC, Smyrk TC, Dina MA, Waugh VM, Rumilla KM.
    Am J Surg Pathol; 2015 Oct; 39(10):1370-6. PubMed ID: 26099011
    [Abstract] [Full Text] [Related]

  • 2. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
    Rabban JT, Calkins SM, Karnezis AN, Grenert JP, Blanco A, Crawford B, Chen LM.
    Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759
    [Abstract] [Full Text] [Related]

  • 3. Germline MLH1 Mutations Are Frequently Identified in Lynch Syndrome Patients With Colorectal and Endometrial Carcinoma Demonstrating Isolated Loss of PMS2 Immunohistochemical Expression.
    Dudley B, Brand RE, Thull D, Bahary N, Nikiforova MN, Pai RK.
    Am J Surg Pathol; 2015 Aug; 39(8):1114-20. PubMed ID: 25871621
    [Abstract] [Full Text] [Related]

  • 4. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
    Mills AM, Sloan EA, Thomas M, Modesitt SC, Stoler MH, Atkins KA, Moskaluk CA.
    Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542
    [Abstract] [Full Text] [Related]

  • 5. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
    Dillon JL, Gonzalez JL, DeMars L, Bloch KJ, Tafe LJ.
    Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
    [Abstract] [Full Text] [Related]

  • 6. Universal Lynch Syndrome Screening Should be Performed in All Upper Tract Urothelial Carcinomas.
    Ju JY, Mills AM, Mahadevan MS, Fan J, Culp SH, Thomas MH, Cathro HP.
    Am J Surg Pathol; 2018 Nov; 42(11):1549-1555. PubMed ID: 30148743
    [Abstract] [Full Text] [Related]

  • 7. Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer.
    Mills AM, Liou S, Ford JM, Berek JS, Pai RK, Longacre TA.
    Am J Surg Pathol; 2014 Nov; 38(11):1501-9. PubMed ID: 25229768
    [Abstract] [Full Text] [Related]

  • 8. Minimal microsatellite shift in microsatellite instability high endometrial cancer: a significant pitfall in diagnostic interpretation.
    Wu X, Snir O, Rottmann D, Wong S, Buza N, Hui P.
    Mod Pathol; 2019 May; 32(5):650-658. PubMed ID: 30443012
    [Abstract] [Full Text] [Related]

  • 9. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
    Goodfellow PJ, Billingsley CC, Lankes HA, Ali S, Cohn DE, Broaddus RJ, Ramirez N, Pritchard CC, Hampel H, Chassen AS, Simmons LV, Schmidt AP, Gao F, Brinton LA, Backes F, Landrum LM, Geller MA, DiSilvestro PA, Pearl ML, Lele SB, Powell MA, Zaino RJ, Mutch D.
    J Clin Oncol; 2015 Dec 20; 33(36):4301-8. PubMed ID: 26552419
    [Abstract] [Full Text] [Related]

  • 10. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
    Cohen R, Buhard O, Cervera P, Hain E, Dumont S, Bardier A, Bachet JB, Gornet JM, Lopez-Trabada D, Dumont S, Kaci R, Bertheau P, Renaud F, Bibeau F, Parc Y, Vernerey D, Duval A, Svrcek M, André T.
    Eur J Cancer; 2017 Nov 20; 86():266-274. PubMed ID: 29055842
    [Abstract] [Full Text] [Related]

  • 11. Diagnosis of Constitutional Mismatch Repair-Deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating Agents.
    Bodo S, Colas C, Buhard O, Collura A, Tinat J, Lavoine N, Guilloux A, Chalastanis A, Lafitte P, Coulet F, Buisine MP, Ilencikova D, Ruiz-Ponte C, Kinzel M, Grandjouan S, Brems H, Lejeune S, Blanché H, Wang Q, Caron O, Cabaret O, Svrcek M, Vidaud D, Parfait B, Verloes A, Knappe UJ, Soubrier F, Mortemousque I, Leis A, Auclair-Perrossier J, Frébourg T, Fléjou JF, Entz-Werle N, Leclerc J, Malka D, Cohen-Haguenauer O, Goldberg Y, Gerdes AM, Fedhila F, Mathieu-Dramard M, Hamelin R, Wafaa B, Gauthier-Villars M, Bourdeaut F, Sheridan E, Vasen H, Brugières L, Wimmer K, Muleris M, Duval A, European Consortium “Care for CMMRD”.
    Gastroenterology; 2015 Oct 20; 149(4):1017-29.e3. PubMed ID: 26116798
    [Abstract] [Full Text] [Related]

  • 12. Challenges in the identification of MSH6-associated colorectal cancer: rectal location, less typical histology, and a subset with retained mismatch repair function.
    Klarskov L, Holck S, Bernstein I, Okkels H, Rambech E, Baldetorp B, Nilbert M.
    Am J Surg Pathol; 2011 Sep 20; 35(9):1391-9. PubMed ID: 21836479
    [Abstract] [Full Text] [Related]

  • 13. Role of endometrial cancer abnormal MMR protein in screening Lynch-syndrome families.
    Long Q, Peng Y, Tang Z, Wu C.
    Int J Clin Exp Pathol; 2014 Sep 20; 7(10):7297-303. PubMed ID: 25400828
    [Abstract] [Full Text] [Related]

  • 14. The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy.
    Chui MH, Ryan P, Radigan J, Ferguson SE, Pollett A, Aronson M, Semotiuk K, Holter S, Sy K, Kwon JS, Soma A, Singh N, Gallinger S, Shaw P, Arseneau J, Foulkes WD, Gilks CB, Clarke BA.
    Am J Surg Pathol; 2014 Sep 20; 38(9):1173-81. PubMed ID: 25025451
    [Abstract] [Full Text] [Related]

  • 15. Targeted gene sequencing of Lynch syndrome-related and sporadic endometrial carcinomas.
    Libera L, Craparotta I, Sahnane N, Chiaravalli AM, Mannarino L, Cerutti R, Riva C, Marchini S, Furlan D.
    Hum Pathol; 2018 Nov 20; 81():235-244. PubMed ID: 30420047
    [Abstract] [Full Text] [Related]

  • 16. Utility of immunohistochemistry in predicting microsatellite instability in endometrial carcinoma.
    Modica I, Soslow RA, Black D, Tornos C, Kauff N, Shia J.
    Am J Surg Pathol; 2007 May 20; 31(5):744-51. PubMed ID: 17460459
    [Abstract] [Full Text] [Related]

  • 17. Microsatellite Instability in Endometrial Carcinoma by Immunohistochemistry, Association with Clinical and Histopathologic Parameters.
    Hashmi AA, Mudassir G, Hashmi RN, Irfan M, Asif H, Khan EY, Abu Bakar SM, Faridi N.
    Asian Pac J Cancer Prev; 2019 Sep 01; 20(9):2601-2606. PubMed ID: 31554352
    [Abstract] [Full Text] [Related]

  • 18. Role of microsatellite instability-low as a diagnostic biomarker of Lynch syndrome in colorectal cancer.
    Vilar E, Mork ME, Cuddy A, Borras E, Bannon SA, Taggart MW, Ying J, Broaddus RR, Luthra R, Rodriguez-Bigas MA, Lynch PM, You YQ.
    Cancer Genet; 2014 Sep 01; 207(10-12):495-502. PubMed ID: 25432668
    [Abstract] [Full Text] [Related]

  • 19. Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy.
    Najdawi F, Crook A, Maidens J, McEvoy C, Fellowes A, Pickett J, Ho M, Nevell D, McIlroy K, Sheen A, Sioson L, Ahadi M, Turchini J, Clarkson A, Hogg R, Valmadre S, Gard G, Dooley SJ, Scott RJ, Fox SB, Field M, Gill AJ.
    Pathology; 2017 Aug 01; 49(5):457-464. PubMed ID: 28669579
    [Abstract] [Full Text] [Related]

  • 20. Clinicopathological comparison of colorectal and endometrial carcinomas in patients with Lynch-like syndrome versus patients with Lynch syndrome.
    Mas-Moya J, Dudley B, Brand RE, Thull D, Bahary N, Nikiforova MN, Pai RK.
    Hum Pathol; 2015 Nov 01; 46(11):1616-25. PubMed ID: 26319271
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.